BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15373671)

  • 1. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery.
    Shariatmadar S; Storry JR; Sausais L; Reid ME
    Immunohematology; 2004; 20(1):63-6. PubMed ID: 15373671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Very severe pregnancy hemolysis...].
    Sève P; Ferry T; Vial T; Stankovic K; Bui-Xuan C; Broussolle C
    Rev Med Interne; 2004 Jun; 25 Suppl 2():S290-1. PubMed ID: 15460484
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotetan-induced hemolysis associated with antibiotic prophylaxis for cesarean delivery.
    Naylor CS; Steele L; Hsi R; Margolin M; Goldfinger D
    Am J Obstet Gynecol; 2000 Jun; 182(6):1427-8. PubMed ID: 10871459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotetan-induced immune hemolytic anemia.
    Chenoweth CE; Judd WJ; Steiner EA; Kauffman CA
    Clin Infect Dis; 1992 Nov; 15(5):863-5. PubMed ID: 1445986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.
    Garratty G; Leger RM; Arndt PA
    Am J Obstet Gynecol; 1999 Jul; 181(1):103-4. PubMed ID: 10411803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotetan disodium-induced hemolytic anemia.
    Wagner BK; Heaton AH; Flink JR
    Ann Pharmacother; 1992 Feb; 26(2):199-200. PubMed ID: 1554932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal immune hemolytic anemia due to cefotetan.
    Garratty G; Nance S; Lloyd M; Domen R
    Transfusion; 1992; 32(3):269-71. PubMed ID: 1557811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotetan-induced immune hemolytic anemia due to the drug-adsorption mechanism.
    Eckrich RJ; Fox S; Mallory D
    Immunohematology; 1994; 10(2):51-4. PubMed ID: 15945790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan.
    Gallagher NI; Schergen AK; Sokol-Anderson ML; Sheahan EJ; Chaplin H
    Transfusion; 1992; 32(3):266-8. PubMed ID: 1557810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotetan-induced hemolytic anemia: a case report and review of the literature.
    Moes GS; MacPherson BR
    Arch Pathol Lab Med; 2000 Sep; 124(9):1344-6. PubMed ID: 10975934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2003 Nov; 43(11):1640-1. PubMed ID: 14617328
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of cefotetan on red blood cells.
    Davenport RD; Judd WJ; Dake LR
    Transfusion; 2004 Jun; 44(6):849-52. PubMed ID: 15157250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced immune hemolytic anemia.
    Garratty G
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):98-101. PubMed ID: 20386530
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study.
    Perkins J
    Asian J Transfus Sci; 2008 Jan; 2(1):20-3. PubMed ID: 20041074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K; Tran H; Hirai-Yang A; Vakil N; Marks G; Klapper E
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan.
    Ray EK; Warkentin TE; O'Hoski PL; Gregor P
    Can J Surg; 2000 Dec; 43(6):461-2. PubMed ID: 11129837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.